Skip to main content
. Author manuscript; available in PMC: 2021 Mar 11.
Published in final edited form as: Clin Nucl Med. 2020 Dec;45(12):e505–e511. doi: 10.1097/RLU.0000000000003318

Table 2.

Cox univariate regression

Cox univariate regression
Hazard ratio 95% confidence interval P value
Sex 1.579 0.551–4.517 0.39
Age (year) 1.03 0.996–1.064 0.083
IDH status (wild-type vs. mutant) 4.939 1.203–20.28 0.026*
1p19q status for IDH mutant (non-codel vs. codel) 0.234 0.042–1.301 0.097
MGMT Status (unmethylated vs. methylated) 0.56 0.078–4.001 0.56
Patient Status (newly diagnosed vs. recurrent) 2.231 0.640–7.766 0.2
nSUVmax 2.827 1.202–6.649 0.017*
FDOPA hypermetabolic volume (mL) 1.048 1.019–1.078 0.001*
FLAIRROI volume (mL) 1.006 1.000–1.013 0.046*
rCBV 1.05 0.214–5.151 0.95
ADClow (×10−6 mm2/s) 1.002 0.999–1.005 0.17

IDH = isocitrate dehydrogenase; MGMT = O6-methylguanine-DNA methyltransferase; rCBV = relative cerebral blood volume; ADC = apparent diffusion coefficient

*

means statistically significant